84499-73-0

Basic information

• Product Name: (S)-1-[4-(Trifluoromethyl)phenyl]ethylamine
• Synonyms: S-PTF-PEM;(S)-1-[4-(TRIFLUOROMETHYL)PHENYL]ETHYLAMINE;(S)-1-(4-(TRIFLUOROMETHYL)PHENYL)ETHANAMINE;(1S)-1-[4-(Trifluoromethyl)phenyl]ethylamine;Benzenemethanamine, α-methyl-4-(trifluoromethyl)-, (αS)-;Benzenemethanamine, .alpha.-methyl-4-(trifluoromethyl)-, (.alpha.S)-;(S)-alpha-Methyl-4-(trifluoromethyl)benzylamine;(S)-1-[4-(TRIFLUOROMETHYL)PHENYL]ETHYLAMINE-HCl
• CAS NO: 84499-73-0
• Molecular Formula: C₉H₁₀F₃N
• Molecular Weight: 189.18
• Product Categories: intermediates
• Mol File: 84499-73-0.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 203.9 °C at 760 mmHg
• Flash Point: 82.9 °C
• Appearance: /
• Density: 1.18 g/cm³
• Vapor Pressure: 5.09mmHg at 25°C
• Refractive Index: 1.285
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: (S)-1-[4-(Trifluoromethyl)phenyl]ethylamine(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-1-[4-(Trifluoromethyl)phenyl]ethylamine(84499-73-0)
• EPA Substance Registry System: (S)-1-[4-(Trifluoromethyl)phenyl]ethylamine(84499-73-0)

Safety Data

• Hazard Codes: Xi
• Hazardous Substances Data: 84499-73-0(Hazardous Substances Data)

Usage

Description

(S)-1-[4-(Trifluoromethyl)phenyl]ethylamine is an organic amine compound with the molecular formula C10H12F3N. It features an amine group attached to a phenyl ring substituted with a trifluoromethyl group at the 4-position and an ethyl group at the alpha position. This chiral compound is known for its potential pharmacological properties and its utility as a precursor in the synthesis of biologically active compounds, making it valuable in pharmaceutical research and drug development.

Uses

Used in Pharmaceutical Research and Drug Development:
(S)-1-[4-(Trifluoromethyl)phenyl]ethylamine is used as a precursor in the synthesis of various biologically active compounds for its potential pharmacological properties. It plays a crucial role in the development of new drugs by providing a structural foundation that can be modified to achieve desired therapeutic effects.
Used in Organic Synthesis:
In the field of organic synthesis, (S)-1-[4-(Trifluoromethyl)phenyl]ethylamine serves as a building block for the creation of more complex molecules. Its unique structure allows for the formation of a wide range of chemical entities, contributing to the advancement of chemical research and the discovery of novel compounds with specific applications.

InChI:InChI=1/C10H2F18/c11-3(12,5(15,16)7(19,20)9(23,24)25)1-2-4(13,14)6(17,18)8(21,22)10(26,27)28/h1-2H/b2-1+

Upstream product

• 581812-91-1 (S)-N-[α-methyl-4-(trifluoromethyl)benzyl] (R)-2-acetoxy-2-phenylethanamide 
• 1737-26-4 1-(4-trifluorophenyl)ethanol 
• 709-63-7 1-(4-trifluoromethylphenyl)ethanone 
• 437762-12-4 (S)-1-phenyl-N-((S)-1-(4-(trifluoromethyl)phenyl)ethyl)ethan-1-amine 
• 444643-05-4 ((S)-1-Phenyl-ethyl)-[(R)-1-(4-trifluoromethyl-phenyl)-ethyl]-amine 
• 672906-91-1 (E)-N-(1-(S)-phenylethyl)ethan-1-(4-(trifluoromethyl)phenyl)-1-imine 
• 107496-43-5 1-(4-(trifluoromethyl)phenyl)ethan-1-one O-methyl oxime 
• 15996-84-6 1-(4-trifluoromethylphenyl)ethylamine 
• 84499-82-1 (S)-2-Acetylamino-4-methyl-pentanoic acid; compound with (S)-1-(4-trifluoromethyl-phenyl)-ethylamine 

Downstream Products

• 870709-68-5 5-isopropyl-2-((S)-1-(4-(trifluoromethyl)phenyl)-ethylamino)thiazol-4(5H)-one 
• 1362627-39-1 C₂₃H₂₉F₃N₂O₃ 
• 1146245-82-0 C₂₄H₂₂F₃N₅O 
• 1256476-23-9 (S)-tert-butyl 4-oxo-3-(pyrrolidin-1-yl)-2-{1-[4-(trifluoromethyl)phenyl]ethylamino}-3,4,7,8-tetrahydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate 
• 1256476-09-1 6-(tert-butoxycarbonyl)-2-(S)-{1-[4-(trifluoromethyl)phenyl]ethylamino}-3-methoxy-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-(3H)-one 
• 1256476-05-7 6-(tert-butoxycarbonyl)-2-(S)-{1-[4-(trifluoromethyl)phenyl]ethylamino}-3-dimethylamino-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-(3H)-one 
• 1256476-02-4 6-(tert-butoxycarbonyl)-2-(S)-{1-[4-(trifluoromethyl)phenyl]ethylamino}-3-propargyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine-4-(3H)-one 
• 1246387-29-0 1-[4-(3-methyl-[1,2,4]oxadiazol-5-yl)-benzoyl]-4-phenyl-piperidine-4-carboxylic acid [(S)-1-(4-trifluoromethyl-phenyl)-ethyl]-amide 
• 1073722-50-5 C₁₄H₁₆F₃NO 

Relevant articles and documents

BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

The present disclosure relates to bifunctional compounds, which find utility as modulators of SMARCA2 or BRM (target protein). In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a ligand that binds to the Von Hippel-Lindau E3 ubiquitin ligase, and on the other end a moiety which binds the target protein, such that the target protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of target protein. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of target protein. Diseases or disorders that result from aggregation or accumulation of the target protein are treated or prevented with compounds and compositions of the present disclosure.

Trading N and O. Part 3: Synthesis of 1,2,3,4-tetrahydroisoquinolines from α-hydroxy-β-amino esters

A range of enantiopure 1,2,3,4-tetrahydroisoquinolines have been prepared directly from α-hydroxy-β-amino esters. Activation of the α-hydroxy group upon treatment with Tf2O and 2,6-di-tert-butyl-4-methylpyridine promotes aziridinium formation,

α-Methylation at benzylic fragment of N-aryl-N′-benzyl ureas provides TRPV1 antagonists with better pharmacokinetic properties and higher efficacy in inflammatory pain model

SAR studies for N-aryl-N′-benzyl urea class of TRPV1 antagonists have been extended to cover α-benzyl alkylation. Alkylated compounds showed weaker in vitro potencies in blocking capsaicin activation of TRPV1 receptor, but possessed improved pharmacokinetic properties. Further structural manipulations that included replacement of isoquinoline core with indazole and isolation of single enantiomer led to TRPV1 antagonists like (R)-16a with superior pharmacokinetic properties and greater potency in animal model of inflammatory pain.